Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06635005 · ClinicalTrials.gov registry record · NA
A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women
A NA study of Feasibility Pilot Study and Compliance, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06635005: Recruiting NA study of Feasibility Pilot Study and Compliance, sponsored by Ohio State University Comprehensive Cancer Center.
NCT06635005 is a NA study of Feasibility Pilot Study and Compliance that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06635005, a NA study of Feasibility Pilot Study and Compliance, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests whether a new dietary pattern that consists of foods that lower the blood insulin response can reduce breast cancer risk in high-risk women. In a large group of patients, this new dietary pattern was associated with reduced risk of multiple cancers and reduced risk of long-term weight gain. Parts of this new dietary pattern are quite different from typical dietary recommendations, and much education is needed. Overall, compared to the typical American diet, this new dietary pattern is moderately low in total fat and saturated fat, low in protein from animal foods but high in protein from plant sources, high in fruits and vegetables, high in whole grains, and high in dietary fiber. We will determine if a low-insulinemic dietary pattern intervention is feasible and effective in reducing breast cancer risk in high-risk women.
Primary Outcome
High compliance will be defined as \> 80% of participants achieving and maintaining scores ≥ median 0.06. Will be measured by the low-Empirical Dietary Index for Hyperinsulinemia scores. Descriptive statistics (i.e., means, standard deviations for continuous variables, and frequencies and percentages for discrete data) will be used to summarize demographics and clinical characteristics of study participants. Will be tested using multivariable-adjusted general linear mixed regression to accommoda
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Medical Device Usage and Evaluation
- OTHER Dietary Intervention
- BEHAVIORAL Motivational Interviewing
- OTHER Nutritional Assessment
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT06635005 shows while recruiting
NCT06635005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Feasibility Pilot Study appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT06635005 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06635005 about?
NCT06635005 is a clinical study titled "A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women". This clinical trial tests whether a new dietary pattern that consists of foods that lower the blood insulin response can reduce breast cancer risk in high-risk women. In a large group of patients, this new dietary pattern was associated with reduced risk of multiple cancers and reduced risk of long-...
What is the current status of trial NCT06635005?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-03. Estimated completion is 2026-03-31.
What conditions does trial NCT06635005 study?
This clinical trial studies the following conditions: Feasibility Pilot Study, Compliance.
What interventions are being tested in trial NCT06635005?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Medical Device Usage and Evaluation (OTHER), Dietary Intervention (OTHER), Motivational Interviewing (BEHAVIORAL), Nutritional Assessment (OTHER).
Who is sponsoring clinical trial NCT06635005?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06635005 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Feasibility Pilot Study
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06635005's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI